X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (664) 664
humans (623) 623
eml4-alk fusion gene (537) 537
oncology (518) 518
lung neoplasms - genetics (385) 385
lung cancer (329) 329
anaplastic lymphoma kinase (306) 306
crizotinib (289) 289
eml4-alk (289) 289
female (286) 286
cancer (274) 274
mutation (268) 268
male (254) 254
lung neoplasms - drug therapy (252) 252
carcinoma, non-small-cell lung - genetics (249) 249
lung neoplasms - pathology (243) 243
receptor protein-tyrosine kinases - genetics (243) 243
lung cancer, non-small cell (229) 229
middle aged (229) 229
adenocarcinoma (227) 227
egfr (221) 221
alk (218) 218
carcinoma, non-small-cell lung - drug therapy (205) 205
identification (199) 199
aged (197) 197
chemotherapy (193) 193
adult (187) 187
respiratory system (187) 187
immunohistochemistry (179) 179
lymphomas (179) 179
oncogene proteins, fusion - genetics (162) 162
mutations (155) 155
cell lung-cancer (154) 154
genetic aspects (154) 154
adenocarcinoma - genetics (152) 152
non-small cell lung cancer (149) 149
carcinoma, non-small-cell lung - pathology (144) 144
gefitinib (144) 144
gene rearrangement (144) 144
protein kinase inhibitors - therapeutic use (144) 144
antineoplastic agents - therapeutic use (135) 135
hemic and lymphatic diseases (134) 134
tumors (131) 131
pathology (127) 127
care and treatment (124) 124
receptor protein-tyrosine kinases - metabolism (118) 118
nsclc (116) 116
aged, 80 and over (115) 115
research (115) 115
lung neoplasms - metabolism (114) 114
in situ hybridization, fluorescence (113) 113
receptor protein-tyrosine kinases - antagonists & inhibitors (107) 107
eml4-alk fusion (106) 106
animals (105) 105
receptor, epidermal growth factor - genetics (102) 102
acquired-resistance (100) 100
open-label (97) 97
hematology, oncology and palliative medicine (96) 96
adenocarcinoma - pathology (93) 93
pyridines - therapeutic use (93) 93
pyrazoles - therapeutic use (92) 92
resistance (92) 92
inhibitor (90) 90
lung neoplasms - diagnosis (89) 89
gene (87) 87
kinases (87) 87
features (86) 86
prognosis (82) 82
analysis (81) 81
growth-factor receptor (80) 80
health aspects (80) 80
protein kinase inhibitors - pharmacology (80) 80
article (79) 79
carcinoma, non-small-cell lung - metabolism (77) 77
adenocarcinoma of lung (74) 74
cell line, tumor (74) 74
metastasis (74) 74
pharmacology & pharmacy (74) 74
epidermal growth factor (73) 73
lung neoplasms - enzymology (72) 72
genes (71) 71
pulmonary/respiratory (71) 71
lung-cancer (68) 68
cancer therapies (67) 67
molecular targeted therapy (67) 67
non-small cell lung carcinoma (66) 66
tyrosine kinase inhibitors (66) 66
egfr mutations (65) 65
neoplasm staging (64) 64
patients (63) 63
lymphoma (62) 62
non-small-cell lung cancer (62) 62
fluorescence in situ hybridization (61) 61
egfr mutation (60) 60
proto-oncogene proteins - genetics (60) 60
respiratory tract diseases (60) 60
tyrosine (60) 60
targeted therapy (58) 58
cell biology (57) 57
proteins (57) 57
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Oncology Reports, ISSN 1021-335X, 10/2012, Volume 28, Issue 4, pp. 1187 - 1192
Journal Article
Lung Cancer, ISSN 0169-5002, 2013, Volume 81, Issue 2, pp. 308 - 310
Journal Article
by Wang, ZY and Wang, W and Kong, XD and Li, GX and Yang, WW
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, ISSN 1940-5901, 2019, Volume 12, Issue 9, pp. 11632 - 11638
Objective: To investigate the clinical efficacy of crizotinib in the treatment of non-small cell lung cancer (NSCLC) with echinoderm microtubule-associated... 
TARGETED THERAPY | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | crizotinib | OSIMERTINIB | NSCLC | non small cell lung cancer | intravenous chemotherapy | EML4-ALK fusion gene | CELL | CHEMOTHERAPY
Journal Article
Journal Article
Genes, ISSN 2073-4425, 07/2018, Volume 9, Issue 7, p. 331
With the development and application of next-generation sequencing (NGS) and target capture technology, the demand for an effective analysis method to... 
Single-end next-generation sequencing data | Single-end gene fusion | Fusion detection | single-end gene fusion | LUNG | READ ALIGNMENT | GENOMES | single-end next-generation sequencing data | EML4-ALK FUSION | RESOLUTION | GENETICS & HEREDITY | STRUCTURAL VARIATION | fusion detection
Journal Article
Journal Article
Lung Cancer, ISSN 0169-5002, 2011, Volume 75, Issue 1, pp. 66 - 72
Abstract Background Anaplastic lymphoma kinase (ALK) fusion gene-positive lung cancer accounts for 4–5% of non-small cell lung carcinoma. A clinical trial of... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | ALK | EML4 | Crizotinib | ALK inhibitor | KIF5B | Lung cancer | TBNA | EBUS | Fusion gene | TRANSBRONCHIAL NEEDLE ASPIRATION | ANAPLASTIC LYMPHOMA | EGFR | EML4-ALK | MEDIASTINAL LYMPH-NODES | ONCOLOGY | RESPIRATORY SYSTEM | RESISTANCE | MUTATIONS | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Microtubule-Associated Proteins - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Neoplasm Staging - methods | Anaplastic Lymphoma Kinase | Neoplasm Metastasis - drug therapy | Serine Endopeptidases - genetics | Aged, 80 and over | Cell Cycle Proteins - genetics | Kinesin - genetics | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Female | Adenocarcinoma - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Gene Fusion | Adenocarcinoma - drug therapy | Immunohistochemistry - methods | Neoplasm Metastasis - genetics | Receptor Protein-Tyrosine Kinases - genetics | Neoplasm Metastasis - pathology | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Medical colleges | Care and treatment | Oncology, Experimental | Genes | Genetic research | Lymphomas | Genetic aspects | Research | Lung cancer, Non-small cell | Cancer
Journal Article